Multicentre, phase II study of gemcitabine and S-1 in patients with advanced biliary tract cancer: TG1308 study.

Nai-Jung ChiangMing-Huang ChenShih-Hung YangChiun HsuChia-Jui YenHsiao-Hui TsouYung-Yeh SuJen-Shi ChenYan-Shen ShanLi-Tzong Chen

Published in: Liver international : official journal of the International Association for the Study of the Liver (2020)

Modified GS showed moderate efficacy with a favourable safety profile in ABTC patients, thus mandating further assessment. ClinicalTrials.gov number: NCT02425137.

Keyphrases

phase ii study
end stage renal disease
chronic kidney disease
newly diagnosed
locally advanced
open label
clinical trial
prognostic factors
papillary thyroid
study protocol
randomized controlled trial
cross sectional
double blind
childhood cancer